These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1149803)

  • 1. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice.
    Yamamoto T; Ueki S
    Eur J Pharmacol; 1975; 32(02):156-62. PubMed ID: 1149803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zotepine on head-twitch induced by L-5-hydroxytryptophan, mescaline and 2,5-dimethoxy-4-methylamphetamine in mice and rats.
    Yamamoto T; Tazoe N; Ueki S; Shimomura K; Satoh H; Mori J
    Jpn J Pharmacol; 1983 Apr; 33(2):319-25. PubMed ID: 6136619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP) on successive sensory discrimination behavior maintained by electrical stimulation of the brain reinforcement in the rat.
    Vincent JH; Lenzer II
    Psychol Rep; 1976 Jun; 38(3 Pt 2):1083-92. PubMed ID: 935303
    [No Abstract]   [Full Text] [Related]  

  • 5. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats.
    Wing LL; Tapson GS; Geyer MA
    Psychopharmacology (Berl); 1990; 100(3):417-25. PubMed ID: 2138338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.
    Yamamoto T; Ueki S
    Pharmacol Biochem Behav; 1981 Jan; 14(1):89-95. PubMed ID: 6258178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
    Tilson HA; Chamberlain JH; Gylys JA
    Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
    Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
    Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
    [No Abstract]   [Full Text] [Related]  

  • 12. Some pharmacological actions of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats and mice.
    Huang J; Ho BT
    J Pharm Pharmacol; 1975 Jan; 27(1):18-22. PubMed ID: 235610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1982 Oct; 17(4):603-7. PubMed ID: 6965276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the behavioral effects of DOM homologs.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.